Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 230 publications
Efficacy of Intravitreal Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy.
Journal: Journal of vitreoretinal diseases
Published: October 20, 2025
Progress in the use of biological therapies to treat paroxysmal nocturnal hemoglobinuria: focus on patient profiling.
Journal: Expert opinion on biological therapy
Published: October 13, 2025
Challenges in optimizing targeted complement inhibitor therapy for paroxysmal nocturnal hemoglobinuria in an expanding treatment landscape
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 01, 2025
Successful switch from pegcetacoplan to iptacopan after repeated severe breakthrough hemolysis events - case report.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 20, 2025
New treatment strategies for paroxysmal nocturnal hemoglobinuria: drug selection in the era of novel complement inhibitors
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: September 03, 2025
Dynamics of the EZ/RPE Loss Ratio on OCT Over Time During Geographic Atrophy Progression and Treatment With Pegcetacoplan.
Journal: Investigative ophthalmology & visual science
Published: August 20, 2025
Higher Doses of Eculizumab may be Beneficial in Paroxysmal Nocturnal Haemoglobinuria in Pregnancy.
Journal: European journal of case reports in internal medicine
Published: July 24, 2025
Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience.
Journal: American journal of hematology
Published: July 17, 2025
Sterile Intraocular Inflammation Following Intravitreal Injections: Pathogenesis, Clinical Features, and Management.
Journal: International ophthalmology clinics
Published: July 02, 2025
Navigating the paroxysmal nocturnal hemoglobinuria (PNH) landscape.
Journal: Clinical advances in hematology & oncology : H&O
Published: July 01, 2025
Erratum to "Visual Function Benefit After Treatment With Pegcetacoplan: Microperimetry Analysis From the Phase 3 OAKS Trial," [Am J Ophthalmol 2025; 273:119-129].
Journal: American journal of ophthalmology
Published: May 30, 2025
Pegcetacoplan for Geographic Atrophy Over 30 Months: Data From OAKS, DERBY, and the GALE Long-Term Extension Study.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: May 15, 2025
Last Updated: 10/31/2025